--2025/Q2-- / 14.243B--
--2025/Q1-- / 12.779B--
Feb 6, 20252024/Q413.533B / 13.431B--
Oct 30, 20242024/Q311.439B / 12.119B--
Strategy
MSTR
Coinbase
COIN
Alphabet-A
GOOGL
Alphabet-C
GOOG
NVIDIA
NVDA
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 911.060
- -18.660-2.01%
Close Mar 4 16:00 ET
- 915.000
- +3.940+0.43%
Post 20:01 ET
863.84BMarket Cap77.80P/E (TTM)
929.160High902.790Low3.34MVolume922.235Open929.720Pre Close3.06BTurnover0.35%Turnover Ratio77.80P/E (Static)948.17MShares969.23352wk High60.87P/B863.03BFloat Cap710.16952wk Low5.20Dividend TTM947.29MShs Float969.233Historical High0.57%Div YieldTTM2.84%Amplitude5.269Historical Low914.297Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q4 2024 Earnings Date
Overview | Strong demand for Mounjaro but prices dip, forecasts over 30% jump in 2025 sales on newer medicines
Currency：USDFeb 6, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 13.43B | 13.53B | +101.55M |
| Beat Est. | +43.60% | +44.68% | +0.76% |
| EPS | 5.01 | 4.88 | -0.13 |
| Miss Est. | +107.01% | +101.65% | -2.59% |
Analyst Rating
Mar 4, 2025
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
